This inventor holds 1 USPTO granted patent. Top assignee: Universidad Nacional De Quilmes. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Guillermo Skilton: Innovator in Cancer Treatment
Introduction
Guillermo Skilton is a notable inventor based in Quilmes, Argentina. He has made significant contributions to the field of medicine, particularly in cancer treatment. His innovative approach focuses on minimizing metastatic dissemination during surgical procedures.
Latest Patents
Guillermo Skilton holds a patent for a method of inhibiting metastatic dissemination using desmopressin. The patent describes the use of 1-deamino-8-D-arginine vasopressin (desmopressin), or a pharmaceutically acceptable salt thereof, in the preparation of a medication aimed at reducing metastatic spread during cancer surgery. This invention also encompasses pharmaceutical compositions that include desmopressin and outlines a method for treating mammals to inhibit metastatic spread during the surgical removal of cancer masses. He has 1 patent to his name.
Career Highlights
Guillermo Skilton is affiliated with the Universidad Nacional de Quilmes, where he continues to advance his research and innovations in the medical field. His work is pivotal in developing new strategies for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Daniel Fernando Alonso and Daniel Eduardo Gomez. Their combined expertise contributes to the advancement of research and innovation in their respective fields.
Conclusion
Guillermo Skilton's contributions to cancer treatment through his innovative patent demonstrate his dedication to medical research and improving surgical outcomes. His work continues to inspire advancements in the field of oncology.